| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ceb2504c8d821ee1e5dd0861abee6d7d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6463354a7641b5e087ddd16c61ef4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b0f5e4856f3ddd1faa1908832c376d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53bb2fea44c51e1fb63a9980a07781da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3679fd56f0ffe8cd8c0ed87c8081d8e |
| publicationDate |
2020-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2020076572-A |
| titleOfInvention |
Tissue fibrosis biomarker |
| abstract |
PROBLEM TO BE SOLVED: To provide a biomarker for a tissue fibrosis disease and a method for using the biomarker. A method for examining a tissue fibrotic disease, which comprises a step of detecting at least one protein selected from a protein group (A) in an extracellular vesicle of a body fluid collected from a subject. A method for examining a tissue fibrotic disease, which comprises the step of determining that the subject suffers from a tissue fibrotic disease when the amount or concentration of the detected protein is not less than the cutoff value. A tissue fibrosis disease, in which the cutoff value is 2.5 to 3.5 times the value of the amount or concentration of the corresponding protein in extracellular vesicles of body fluid collected from a subject not suffering from tissue fibrosis disease. Inspection method. [Selection diagram] None |
| priorityDate |
2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |